Journal for ImmunoTherapy of Cancer (Nov 2023)
29 Immune modulation and baseline biomarker correlation with clinical benefit following treatment with COM701+nivolumab+/-BMS-986207 in patients with platinum resistant ovarian cancer
Abstract
No abstracts available.